Investidea: компания Cryoport, потому что заморозка

  Today we have an extremely speculative idea.: take shares in software and drug development vendor Cryoport (NASDAQ: CYRX), in order to earn on a positive conjuncture for the company. Growth potential and validity: 21% behind 15 Months; 42% behind 3 of the year.